Associate-Professor, Pharmaceutical Sciences, Midwestern University
BIOGRAPHY
FEB 21, 2018 10:30 AM PST
Panel Discussion: Co-development of Drugs and Companion Diagnostics
Presented at:
Drug Discovery Virtual Event Series 2018
Speakers
-
Martin Shaw
Business Development, AroCell ABBIOGRAPHY -
Thomas Webster, PhD
Professor and Department Chair, Chemical Engineering, Art Zafiropoulo Chair in Engineering, Affiliated Faculty, Bioengineering, Northeastern University, College of EngineeringBIOGRAPHY
Abstract
The distinction between "complementary" and "companion" diagnostics tests confuse many physicians and healthcare professionals. Panelists Professor Thomas Webster (Northeastern University) and Dr. Martin Shaw (AroCell AB) will discuss the differences between "complementary" and "companion" diagnostics and why both are important.
You May Also Like
OCT 24, 2023 | 10:00 AM
Dynamic changes in chromatin drive gene expression programs during cellular development and contribute to pathological changes underlying disease. To date, efforts to characterize chromatin...
MAR 26, 2024 | 11:00 AM
Ever wonder what you’re missing in your data? The sheer complexity of today’s flow and mass cytometry datasets demands automated solutions. Machine learning plugins only provide...
FEB 08, 2024 | 10:00 AM
High-content screening (HCS) is an imaging-based, multi-parametric strategy used in drug development that generates rich datasets through multiplexing strategically chosen fluorescent dyes a...
NOV 14, 2023 | 6:00 AM
C.E. CREDITS
It is over half a century since haemoglobin A1c (HbA1c) was recognised by medical professionals; the importance of HbA1c to the long term health of people with diabetes was clearly demonstra...
MAR 26, 2024 | 7:00 PM
C.E. CREDITS
The implementation of a preemptive pharmacogenomics (PGx) program in a hospital setting requires a multidisciplinary approach to ensure seamless integration of each stage of the process for...
MAR 26, 2024 | 8:00 AM
C.E. CREDITS
The implementation of a preemptive pharmacogenomics (PGx) program in a hospital setting requires a multidisciplinary approach to ensure seamless integration of each stage of the process for...
FEB 21, 2018 10:30 AM PST
Share
Panel Discussion: Co-development of Drugs and Companion Diagnostics
Presented at:
Drug Discovery Virtual Event Series 2018
Loading Comments...
Finish Registering
-
APR 30, 2024Immuno-Oncology Virtual Event Series 2024
-
MAY 07, 20243rd International Biosecurity Virtual Symposium
-
JUN 06, 2024The Future of Scientific Conferencing
- See More
-
APR 24, 2024
- See More
